Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B de Vries

Showing results (91-100 of 218) with videos related to

Pageof 22
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|June 27, 1992
[Fragile X syndrome: basal defect, diagnosis and genetic counseling]L B de Vries, J M Verkerk, M F Niermeijer, et al.
Pharmeuropa Bio & Scientific Notes|February 11, 2010
Collaborative study for the validation of alternative in vitro potency assays for human tetanus immunoglobulinS Gross, S W J Janssen, B de Vries, et al.
Biologicals : Journal of the International Association of Biological Standardization|April 20, 2010
Collaborative study for the validation of alternative in vitro potency assays for human tetanus immunoglobulinsS Gross, S W J Janssen, B de Vries, et al.
Journal of the Autonomic Nervous System|October 5, 1995
Neural influences on the iris of diabetic rats and effect of oculomotor nerve crushW P Vandertop, W B de Vries, N C Notermans, et al.
The Journal of Pediatrics|August 16, 2011
B-type natriuretic peptide and rebound during treatment for persistent pulmonary hypertensionDaniel C Vijlbrief, Manon J N L Benders, Hans Kemperman, et al.
Journal of Medical Genetics|May 19, 2001
Submicroscopic subtelomeric 1qter deletions: a recognisable phenotype?B B De Vries, S J Knight, T Homfray, et al.
Journal of Medical Genetics|March 2, 1999
Dilemmas in counselling females with the fragile X syndromeB B de Vries, H M van den Boer-van den Berg, M F Niermeijer, et al.
Research and Practice in Thrombosis and Haemostasis|August 25, 2021
Convenience and satisfaction in direct oral anticoagulant-treated patients with atrial fibrillationMargriet Piersma-Wichers, Tessa Elling, Anne M B de Vries-Bots, et al.
Pediatric Research|July 17, 2012
Use of cardiac biomarkers in neonatologyDaniel C Vijlbrief, Manon J N L Benders, Hans Kemperman, et al.
Neonatology|August 22, 2012
Cardiac biomarkers as indicators of hemodynamic adaptation during postasphyxial hypothermia treatmentD C Vijlbrief, M J N L Benders, H Kemperman, et al.
Pageof 22

Showing results (91-100 of 218) with videos related to

Sort By:
Pageof 22
Nederlands Tijdschrift Voor Geneeskunde|June 27, 1992
[Fragile X syndrome: basal defect, diagnosis and genetic counseling]L B de Vries, J M Verkerk, M F Niermeijer, et al.
Pharmeuropa Bio & Scientific Notes|February 11, 2010
Collaborative study for the validation of alternative in vitro potency assays for human tetanus immunoglobulinS Gross, S W J Janssen, B de Vries, et al.
Biologicals : Journal of the International Association of Biological Standardization|April 20, 2010
Collaborative study for the validation of alternative in vitro potency assays for human tetanus immunoglobulinsS Gross, S W J Janssen, B de Vries, et al.
Journal of the Autonomic Nervous System|October 5, 1995
Neural influences on the iris of diabetic rats and effect of oculomotor nerve crushW P Vandertop, W B de Vries, N C Notermans, et al.
The Journal of Pediatrics|August 16, 2011
B-type natriuretic peptide and rebound during treatment for persistent pulmonary hypertensionDaniel C Vijlbrief, Manon J N L Benders, Hans Kemperman, et al.
Journal of Medical Genetics|May 19, 2001
Submicroscopic subtelomeric 1qter deletions: a recognisable phenotype?B B De Vries, S J Knight, T Homfray, et al.
Journal of Medical Genetics|March 2, 1999
Dilemmas in counselling females with the fragile X syndromeB B de Vries, H M van den Boer-van den Berg, M F Niermeijer, et al.
Research and Practice in Thrombosis and Haemostasis|August 25, 2021
Convenience and satisfaction in direct oral anticoagulant-treated patients with atrial fibrillationMargriet Piersma-Wichers, Tessa Elling, Anne M B de Vries-Bots, et al.
Pediatric Research|July 17, 2012
Use of cardiac biomarkers in neonatologyDaniel C Vijlbrief, Manon J N L Benders, Hans Kemperman, et al.
Neonatology|August 22, 2012
Cardiac biomarkers as indicators of hemodynamic adaptation during postasphyxial hypothermia treatmentD C Vijlbrief, M J N L Benders, H Kemperman, et al.
Pageof 22